Published in Euro Surveill on January 19, 2012
Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages. Cell Microbiol (2013) 1.06
Coxiella burnetii type IV secretion-dependent recruitment of macrophage autophagosomes. Infect Immun (2014) 0.95
High Coxiella burnetii DNA load in serum during acute Q fever is associated with progression to a serologic profile indicative of chronic Q fever. J Clin Microbiol (2013) 0.88
Assessing the long-term health impact of Q-fever in the Netherlands: a prospective cohort study started in 2007 on the largest documented Q-fever outbreak to date. BMC Infect Dis (2012) 0.86
Prevalence of chronic Q fever in patients with a history of cardiac valve surgery in an area where Coxiella burnetii is epidemic. Clin Vaccine Immunol (2012) 0.85
Coxiella burnetii seroprevalence and risk factors in sheep farmers and farm residents in The Netherlands. Epidemiol Infect (2013) 0.84
Coxiella burnetii seroprevalence and risk for humans on dairy cattle farms, the Netherlands, 2010-2011. Emerg Infect Dis (2014) 0.83
Decontamination of high-risk animal and zoonotic pathogens. Biosecur Bioterror (2013) 0.81
Large regional differences in serological follow-up of Q fever patients in the Netherlands. PLoS One (2013) 0.81
Serology in chronic Q fever is still surrounded by question marks. Eur J Clin Microbiol Infect Dis (2014) 0.80
Targeted screening as a tool for the early detection of chronic Q fever patients after a large outbreak. Eur J Clin Microbiol Infect Dis (2012) 0.80
Early diagnosis and treatment of patients with symptomatic acute Q fever do not prohibit IgG antibody responses to Coxiella burnetii. Clin Vaccine Immunol (2012) 0.78
Persistent high IgG phase I antibody levels against Coxiella burnetii among veterinarians compared to patients previously diagnosed with acute Q fever after three years of follow-up. PLoS One (2015) 0.78
The Type IV Secretion System Effector Protein CirA Stimulates the GTPase Activity of RhoA and Is Required for Virulence in a Mouse Model of Coxiella burnetii Infection. Infect Immun (2016) 0.77
Single nucleotide polymorphisms in immune response genes in acute Q fever cases with differences in self-reported symptoms. Eur J Clin Microbiol Infect Dis (2015) 0.77
Long-Term Serological Follow-Up of Acute Q-Fever Patients after a Large Epidemic. PLoS One (2015) 0.76
Population Screening for Chronic Q-Fever Seven Years after a Major Outbreak. PLoS One (2015) 0.75
Diagnosis of Coxiella burnetii infection: comparison of a whole blood interferon-gamma production assay and a Coxiella ELISPOT. PLoS One (2014) 0.75
Dysregulation of serum gamma interferon levels in vascular chronic Q Fever patients provides insights into disease pathogenesis. Clin Vaccine Immunol (2015) 0.75
Coverage of the 2011 Q fever vaccination campaign in the Netherlands, using retrospective population-based prevalence estimation of cardiovascular risk-conditions for chronic Q fever. PLoS One (2015) 0.75
Persistent high antibody titres against Coxiella burnetii after acute Q fever not explained by continued exposure to the source of infection: a case-control study. BMC Infect Dis (2014) 0.75
Coxiella burnetii Seroprevalence and Risk Factors in Cattle Farmers and Farm Residents in Three Northeastern Provinces and Inner Mongolia Autonomous Region, China. Biomed Res Int (2016) 0.75
Vaccination against Q fever for biodefense and public health indications. Front Microbiol (2014) 0.75
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science (1997) 5.55
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med (1998) 5.08
Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem (1999) 4.83
Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr (1997) 3.80
Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin Infect Dis (1993) 3.63
Phenotypic and genotypic changes in a new clone complex of Neisseria meningitidis causing disease in The Netherlands, 1958-1990. J Infect Dis (1994) 3.50
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Molecular epidemiology of human enteric caliciviruses in The Netherlands. J Infect Dis (2000) 2.69
Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill (2010) 2.62
Large ongoing Q fever outbreak in the south of The Netherlands, 2008. Euro Surveill (2008) 2.48
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1998) 2.39
Lack of discriminating signs and symptoms in clinical diagnosis of influenza of patients admitted to the hospital. Infection (2007) 2.35
Investigation of a Q fever outbreak in a rural area of The Netherlands. Epidemiol Infect (2009) 2.30
Sustained intensive transmission of Q fever in the south of the Netherlands, 2009. Euro Surveill (2009) 2.29
Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis (2010) 2.26
Nasal carriage and peritonitis by Staphylococcus aureus in patients on continuous ambulatory peritoneal dialysis: a prospective study. Perit Dial Int (1997) 2.19
Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect (2008) 2.01
Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis (2007) 1.97
[Clostridium difficile ribotype 027, toxinotype III in The Netherlands]. Ned Tijdschr Geneeskd (2005) 1.88
Internet-based monitoring of influenza-like illness in the general population: experience of five influenza seasons in The Netherlands. Vaccine (2009) 1.84
Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006. J Clin Microbiol (2008) 1.80
Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots. Eur J Clin Microbiol Infect Dis (2011) 1.65
Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. J Infect (2011) 1.61
Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill (2007) 1.55
Usefulness of seroconversion rates for comparing infection pressures between countries. Epidemiol Infect (2010) 1.53
A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule. Am J Gastroenterol (2000) 1.50
[The molecular epidemiology of hepatitis A in The Netherlands; the usefulness of typing isolated viral strains]. Ned Tijdschr Geneeskd (2007) 1.49
Influence of perinatal conditions on C-reactive protein production. J Pediatr (1992) 1.43
[Inadequate infrastructure for follow-up after needlestick injuries in the Netherlands]. Ned Tijdschr Geneeskd (2008) 1.38
Lyme borreliosis in the Netherlands: strong increase in GP consultations and hospital admissions in past 10 years. Euro Surveill (2006) 1.33
Biological cloning of functionally diverse quasispecies of HIV-1. AIDS Res Hum Retroviruses (1993) 1.29
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy. J Infect Dis (1999) 1.28
Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands. Eur J Clin Microbiol Infect Dis (1996) 1.26
Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut (2000) 1.24
Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy. AIDS (1998) 1.21
Low seroprevalence of Q fever in The Netherlands prior to a series of large outbreaks. Epidemiol Infect (2011) 1.21
Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy. Proc Natl Acad Sci U S A (2000) 1.20
Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill (2009) 1.18
Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1999) 1.16
Emergence of Escherichia coli encoding Shiga toxin 2f in human Shiga toxin-producing E. coli (STEC) infections in the Netherlands, January 2008 to December 2011. Euro Surveill (2014) 1.14
Q fever outbreak in the Netherlands: a preliminary report. Euro Surveill (2007) 1.13
Acyl and alkyl chain length of GPI-anchors is critical for raft association in vitro. FEBS Lett (1999) 1.13
Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS (1999) 1.12
Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med (2001) 1.11
Letter to the editor: influenza vaccine effectiveness: heterogeneity in estimates for the 2012/13 season. Euro Surveill (2013) 1.10
Relation between Q fever notifications and Coxiella burnetii infections during the 2009 outbreak in The Netherlands. Euro Surveill (2012) 1.08
Data quality of 5 years of central norovirus outbreak reporting in the European Network for food-borne viruses. J Public Health (Oxf) (2007) 1.08
Apocytochrome c binding to negatively charged lipid dispersions studied by spin-label electron spin resonance. Biochemistry (1986) 1.06
Prevalence, characterisation and clinical profiles of Shiga toxin-producing Escherichia coli in The Netherlands. Clin Microbiol Infect (2008) 1.06
Specific and sensitive detection of Neisseria gonorrhoeae in clinical specimens by real-time PCR. J Clin Microbiol (2005) 1.05
Molecular aspects of the bilayer stabilization induced by poly(L-lysines) of varying size in cardiolipin liposomes. Biochim Biophys Acta (1985) 1.05
Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia. Clin Microbiol Infect (2012) 1.04
Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses. Euro Surveill (2009) 1.04
A review of diagnostic tests for congenital syphilis in newborns. Eur J Clin Microbiol Infect Dis (2010) 1.02
Evaluation of commonly used serological tests for detection of Coxiella burnetii antibodies in well-defined acute and follow-up sera. Clin Vaccine Immunol (2012) 1.02
Laboratory capability in Europe for foodborne viruses. Euro Surveill (2002) 1.02
Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection. Immunol Lett (1999) 1.02
Clinical manifestations and course of meningococcal disease in 562 patients. Scand J Infect Dis (1996) 1.02
[Antibiotic resistance in Escherichia coli O157 isolated between 1998 and 2003 in The Netherlands]. Tijdschr Diergeneeskd (2007) 1.01
Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011. Euro Surveill (2014) 1.00
A beef-associated outbreak of Salmonella Typhimurium DT104 in The Netherlands with implications for national and international policy. Epidemiol Infect (2007) 1.00
The Dienes phenomenon: competition and territoriality in Swarming Proteus mirabilis. J Bacteriol (2009) 0.99
Is the mitochondrial precursor protein apocytochrome c able to pass a lipid barrier? J Biol Chem (1984) 0.99
Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliable. Vaccine (2002) 0.98
Studies on the lipid dependency and mechanism of the translocation of the mitochondrial precursor protein apocytochrome c across model membranes. J Biol Chem (1986) 0.97
One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings. Infection (2010) 0.96
Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease. Clin Diagn Lab Immunol (1995) 0.96
The efficacy of meningococcal polysaccharide vaccine in preventing group A meningococcal disease in The Gambia, West Africa. Trans R Soc Trop Med Hyg (1986) 0.95
Changing epidemiology of melioidosis? A case of acute pulmonary melioidosis with fatal outcome imported from Brazil. Epidemiol Infect (2005) 0.95
Etiology of acute gastroenteritis in children requiring hospitalization in the Netherlands. Eur J Clin Microbiol Infect Dis (2011) 0.93
In search of hidden Q-fever outbreaks: linking syndromic hospital clusters to infected goat farms. Epidemiol Infect (2010) 0.93
Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008. Antiviral Res (2009) 0.92
Detection of Haemophilus influenzae with monoclonal antibody. Lancet (1987) 0.92
The application of an enzyme-linked immunosorbent assay or an immunofluorescent assay test leads to different estimates of seroprevalence of Coxiella burnetii in the population. Epidemiol Infect (2011) 0.92
Molecular epidemiology of hepatitis A in Noord-Brabant, The Netherlands. J Clin Virol (2005) 0.92
Bacteremia due to Streptococcus gallolyticus, or the perils of revised nomenclature in bacteriology. Clin Infect Dis (2005) 0.92
Outbreak of Salmonella Thompson in the Netherlands since July 2012. Euro Surveill (2012) 0.92
Preferential lipid association and mode of penetration of apocytochrome c in mixed model membranes as monitored by tryptophanyl fluorescence quenching using brominated phospholipids. Biochim Biophys Acta (1987) 0.90
Influenza vaccine effectiveness, 2010/11. Euro Surveill (2011) 0.90
Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027. J Med Microbiol (2008) 0.90
A combination of interferon-gamma and interleukin-2 production by Coxiella burnetii-stimulated circulating cells discriminates between chronic Q fever and past Q fever. Clin Microbiol Infect (2013) 0.89
Tea flavonoids: bioavailability in vivo and effects on cell signaling pathways in vitro. Antioxid Redox Signal (2001) 0.89
Changes in the activities of key enzymes of glycolysis during the cell cycle in yeast: a rectification. J Gen Microbiol (1991) 0.89
High Coxiella burnetii DNA load in serum during acute Q fever is associated with progression to a serologic profile indicative of chronic Q fever. J Clin Microbiol (2013) 0.88
Time-course of antibody responses against Coxiella burnetii following acute Q fever. Epidemiol Infect (2012) 0.88